Dr. Toni Gabaldón and Dr. Salvador Aznar Benitah have been awarded ERC Proof of Concept grants aimed at halting cancer metastasis and optimising sequencing techniques, respectively.
Dr. Salvador Aznar Benitah's PalmitoMET project, backed by an ERC Proof of Concept grant, targets the enzyme driving palmitic acid metabolism to halt cancer metastasis. Led by IRB Barcelona's Stem Cells and Cancer lab, this initiative aims to develop novel drugs that block this metabolic pathway, potentially offering a therapeutic breakthrough for metastatic cancer patients.
Meanwhile, Dr. Toni Gabaldón's MultiSeq project, funded by another ERC Proof of Concept grant, focuses on optimising sequencing processes to reduce time and cost. Collaborating with the BSC, this innovative solution allows for parallel sequencing of multiple samples, promising significant advancements in sequencing accessibility and benefiting the scientific community and society at large.
More information on Dr. Gabaldón’s project: https://www.irbbarcelona.org/en/news/institutional/multiseq-project-receives-funding-erc-optimise-sequencing-and-explore-market
More information on Dr. Aznar Benitah’s project: https://www.irbbarcelona.org/en/news/institutional/erc-proof-concept-grant-halt-cancer-metastasis-targeting-lipid-metabolism
